New diabetes clinical trial: A Study of RAY1225 in Participants With Type 2 Diabetes

Published on: February 11, 2024 at 11:00PM
Conditions: T2DM (Type 2 Diabetes Mellitus)
Interventions: Drug: RAY1225; Drug: Placebo
Sponsors: Guangdong Raynovent Biotech Co., Ltd
Not yet recruiting
https://ift.tt/75YXI9p